211 related articles for article (PubMed ID: 17335185)
1. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Primofiore G; Taliani S; Da Settimo F; Marini AM; La Motta C; Simorini F; Patrizi MP; Sergianni V; Novellino E; Greco G; Cosimelli B; Calderone V; Montali M; Besnard F; Martini C
J Med Chem; 2007 Apr; 50(7):1627-34. PubMed ID: 17335185
[TBL] [Abstract][Full Text] [Related]
2. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
[TBL] [Abstract][Full Text] [Related]
3. Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamides.
Primofiore G; Da Settimo F; Marini AM; Taliani S; La Motta C; Simorini F; Novellino E; Greco G; Cosimelli B; Ehlardo M; Sala A; Besnard F; Montali M; Martini C
J Med Chem; 2006 Apr; 49(8):2489-95. PubMed ID: 16610792
[TBL] [Abstract][Full Text] [Related]
4. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
Primofiore G; Settimo FD; Taliani S; Marini AM; Novellino E; Greco G; Lavecchia A; Besnard F; Trincavelli L; Costa B; Martini C
J Med Chem; 2001 Jul; 44(14):2286-97. PubMed ID: 11428922
[TBL] [Abstract][Full Text] [Related]
5. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
6. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
[TBL] [Abstract][Full Text] [Related]
7. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1996 Dec; 39(26):5083-91. PubMed ID: 8978839
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis.
Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM
J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648
[TBL] [Abstract][Full Text] [Related]
10. High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives.
Primofiore G; Da Settimo F; Taliani S; Salerno S; Novellino E; Greco G; Cosimelli B; Besnard F; Costa B; Montali M; Martini C
J Med Chem; 2005 Apr; 48(8):2936-43. PubMed ID: 15828832
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
[TBL] [Abstract][Full Text] [Related]
12. Isosteric replacement of amide by ester function. Synthesis and benzodiazepine receptor affinity of indol-3-ylglyoxylyl ester derivatives.
Da Settimo A; Primofiore G; Marini AM; Da Settimo F; Nuti V; Martini C; Trincavelli L; Lucacchini A
Farmaco; 1997; 52(6-7):421-8. PubMed ID: 9372593
[TBL] [Abstract][Full Text] [Related]
13. CNS 7056: a novel ultra-short-acting Benzodiazepine.
Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore/receptor models for GABA(A)/BzR alpha2beta3gamma2, alpha3beta3gamma2 and alpha4beta3gamma2 recombinant subtypes. Included volume analysis and comparison to alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2 subtypes.
He X; Huang Q; Ma C; Yu S; McKernan R; Cook JM
Drug Des Discov; 2000; 17(2):131-71. PubMed ID: 11045902
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET.
Bennacef I; Haile CN; Schmidt A; Koren AO; Seibyl JP; Staley JK; Bois F; Baldwin RM; Tamagnan G
Bioorg Med Chem; 2006 Nov; 14(22):7582-91. PubMed ID: 16908169
[TBL] [Abstract][Full Text] [Related]
16. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
[TBL] [Abstract][Full Text] [Related]
17. From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair.
Cosimelli B; Cosconati S; Marinelli L; Novellino E; Greco G
Curr Top Med Chem; 2012; 12(4):321-32. PubMed ID: 22204482
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs.
Falcó JL; Lloveras M; Buira I; Teixidó J; Borrell JI; Méndez E; Terencio J; Palomer A; Guglietta A
Eur J Med Chem; 2005 Nov; 40(11):1179-87. PubMed ID: 16095764
[TBL] [Abstract][Full Text] [Related]
19. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
20. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
